Analyst stock forecast
Heron Therapeutics, Inc. Stock Forecast and Analyst Price Target
HRTX analyst target range, upside, consensus rating and coverage count.
Direct answer
Heron Therapeutics, Inc.'s average price target is $7.00.
The target implies +1,972.8% from the recorded current price, and the consensus rating is Hold.
The verified range is $5.00 to $9.00, with 3 analysts in the current consensus when available.
Forecast evidence checked August 14, 2026.
Get free Heron Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.34
- Average price target
- $7.00
- High price target
- $9.00
- Low price target
- $5.00
- Target upside
- +1,972.8%
- Consensus rating
- Hold
- Analysts
- 3
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026